MCIA
CELG

Mountain Capital Investment Advisors’s Celgene Corp CELG Stock Holding History

Mountain Capital Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-53
Closed -$8K – 522
2017
Q3 		$8K Hold
53
– – 0.01% 305
2017
Q2 		$7K Buy
+53
New +$6.49K 0.01% 348

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mountain Capital Investment Advisors's CELG Position: Q4 2017 in Review

Mountain Capital Investment Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 53 shares — an estimated $8K sold.

Mountain Capital Investment Advisors first reported a position in CELG in Q2 2017 and held it in 2 quarters. The position peaked at $8K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Mountain Capital Investment Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 53 Celgene Corp shares in Q4 2017, an estimated $8K.
  • Mountain Capital Investment Advisors first reported a position in Celgene Corp in Q2 2017 and held it in 2 quarters.
  • Mountain Capital Investment Advisors's Celgene Corp position peaked at $8K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Mountain Capital Investment Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.